Digestive Diseases and Sciences

, Volume 49, Issue 6, pp 954–964 | Cite as

Prognostic Significance of Mucin Expression in Gastric Carcinoma

  • Belma Kocer
  • Atilla Soran
  • Gulten Kiyak
  • Sibel Erdogan
  • Abdullah Eroglu
  • Betül Bozkart
  • Cem Solak
  • Omer Cengiz


In patients with gastric carcinomas, the role of the alteration of mucin expression in overall survivalhas been a matter of some speculation, but few studies have been reported. The aim of our studywas to determine the relationship between MUC1, MUC2, and MUC5AC expression and patientsurvival, with a secondary aim designed to investigate the alteration of MUC expression withinvarious clinicopathologic parameters. Forty-four specimens from gastric carcinoma patients wereimmunohistochemically evaluated using the monoclonal antibodies for MUC1 (EMA, clone E29),MUC2 (CCP58), and MUC5AC (human gastric mucin, clone 45M1). MUC1 expression increasedin gastric carcinoma. MUC1 positivity was determined to be statistically significant, with poor clin-icopathologicalparameters and decreased long-term survival. MUC5AC expression decreased ingastric carcinoma. In addition, patients with MUC5AC-positive tumors also had poor clinicopatho-logicalparameters and showed shorter survival than those with MUC5AC-negative tumors. MUC2expression was not significantly associated with patient survival. We confirmed that the expressionof mucins is associated with characteristics of differentiation in gastric carcinoma. Poor patientoutcomes were seen in gastric carcinomas with MUC1 mucin expression and MUC5AC positivity.

gastric carcinoma MUC1 MUC2 MUC5AC prognosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gendler SJ, Spicer AP: Epithelial mucin genes. Annu Rev Physiol 57: 607–634, 1995Google Scholar
  2. 2.
    Lapensee L, Paquette Y, Bleau G: Alleic polymorphism and chromosomal localization of the human oviductin gene (MUC 9). Fertil Steril 68: 702–708, 1997Google Scholar
  3. 3.
    Shankar V, Pictan P, Eddy JR, Tank V, Nowak N, Sait SN, Shows TB, Schultz RE, Gotway G, Elkins RC, Gilmore MS, Sachdev GP: Localization of human mucin gene (MUC 8) and the cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol 16: 232–241, 1997Google Scholar
  4. 4.
    Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR and Antalis TM: Two novel mucin genes down-regulated in colorec-tal cancer idendified by differential display. Cancer Res 59: 4083–4089, 1999Google Scholar
  5. 5.
    Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS: Heterogeneity of mucin gene expression in normal neoplastic tissues. Cancer Res 53: 641–651, 1993Google Scholar
  6. 6.
    Ho SB, Shekels LL, Toribara NW, Kim YS, Lyftogt C, Cherwitz DL, Niehans GA: Mucin gene expression in normal, preneo-plastic and human gastric epithelium. Cancer Res 55: 2681–2690, 1995Google Scholar
  7. 7.
    Reis CA, David L, Seixas M, Burcell J, Sobrinho-Simoes M: Ex-pression of fully and under-glycosylated forms of MUC 1 mucin in gastric carcinoma. Int J Cancer 79: 402–410, 1998Google Scholar
  8. 8.
    Reis CAH, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roeptorff P, Sobrinho-Simoes M.: Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74: 112–121, 1997Google Scholar
  9. 9.
    Reis CA, David L, Carvalho F, Mandel U, De Bolos C, Mirgorodskaya E, Clausen H, Sobrinho-Simoes M: Immunohisto-chemical study of the expression of MUC6mucin and Co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem 48: 377–388, 2000Google Scholar
  10. 10.
    Van Klinken JW, Dekker J, Büller HA, De Bolos C, Einarhand ACW: Biosynthesis of mucins (MUC2–6) along the longitudinal axis of the human gastrointestinal tract. Am J Physiol 36: G296–G302, 1997Google Scholar
  11. 11.
    Carrato C, Balague C, De Bolos C, Gonzalez E, Gambus G, Planas J, Perini JM, Andreu D, Real FX: Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroen-terology 107: 160–172, 1994Google Scholar
  12. 12.
    Taylor KL, Mall AS, Barnard RA, Ho SB, Cruse JP: Immunohis-tochemical detection of gastric mucin in normal and disease states. Oncology Res 10: 465–473, 1998Google Scholar
  13. 13.
    Lee HS, Lee HK, Kim HS, Yang HK, Kim Y II, Kim WH: MUC1, MUC2, MUC5AC, and MUC6 expression in gastric carcinomas. Their roles as prognostic indicators. Cancer 92: 1427–1434, 2001Google Scholar
  14. 14.
    Pinto-de-Sousa J, David L, Reis CA, Gomes R, Silva L, Pimenta A: Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma. Virchows Arch 440: 304–310, 2002Google Scholar
  15. 15.
    Baldus SE, Zirbes TK, Engel S, Hanisch FG, Mönig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H, Dienes HP: Corre-lation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer 79: 133–138, 1998Google Scholar
  16. 16.
    Baldus SE, Mönig SP, Arkenau V, Hanisch FG, Scheider PM, Thiele J, Holscher AH, Dienes HP: Correlation of MUC5AC im-munoreactivity with histopathological subtypes and prognosis of gastric carcinomas. Ann Surg Oncol 9: 887–893, 2002Google Scholar
  17. 17.
    Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E.: Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients. Clin Can Res 4: 2605–2614, 1998Google Scholar
  18. 18.
    Gurbuz Y, Kahlke V, Klöppel G: How do gastric carcinoma classification system relate to mucin expression patters? An immuno-histochemical analysis in a series of advanced gastric carcinomas. Virchows Arch 440: 505–511, 2002Google Scholar
  19. 19.
    Sobin LH, Wittekind C: TNM Classification of Malignant Tumors, 5th ed. New York, Wiley, 1997Google Scholar
  20. 20.
    Watanabe H, Jass JR, Sobin LH: Histological Typing of Oesophageal and Gastric Tumors, 2nd ed. Berlin, Springer, 1990.Google Scholar
  21. 21.
    Lauren P: The two main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64: 31–49, 1965Google Scholar
  22. 22.
    Ming SC: Gastric carcinoma: A pathobiological classification. Cancer 39: 31–49, 1977Google Scholar
  23. 23.
    Hilkens J, Ligtenberg JL, Vos HL, Litvinov SV: Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17: 359–363, 1992Google Scholar
  24. 24.
    Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J: Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129: 255–265, 1995Google Scholar
  25. 25.
    Van de Wiel-van Kemenade E, Ligtenberg MJ, de Boer AJ, Buijs F, Vos HL, Melief CJ, Hilkens J, Figdor CG: Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J Immunol 151: 767–776, 1993Google Scholar
  26. 26.
    Ligtenberg MJ, Buijs F, Vos HL, Litvinov SV: Suppression of cellular aggregation by high levels of episialin. Cancer Res 52: 2318–2324, 1992Google Scholar
  27. 27.
    Hiraga Y, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F, Kohno N: Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology 55: 307–319, 1998Google Scholar
  28. 28.
    Hanski C, Hofmeier M, Schmitt-Graft A, Riede E, Hanski ML, Borchard F, Sieber E, Niedobitek F, Foss HD, Stein H, Riecken EO: Overexpression or ectopic expression of MUC 2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol 182: 385–391, 1997Google Scholar
  29. 29.
    Kocer B, Soran A, Erdogan S, Ertan T, Unal B, Erel S, Cengiz O: Does MUC 2 expression in colorectal carcinoma affect prognosis; Review of 41 patients. Nagoya Med J 45: 75–87, 2001Google Scholar
  30. 30.
    Gambus G, De Bolos C, Andreu D, Franci C, Egea G, Real FX: Detection of the MUC2 apomucin tandem repeat with a mouse mon-oclonal antibody. Gastroenterology 104: 93–102, 1993Google Scholar
  31. 31.
    Reis CA, David L, Correa P, Carneiro F, De Bolos C, Elsa Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M: Intestinal metaplasia of human stomach displays distinch patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59: 1003–1007, 1999Google Scholar
  32. 32.
    Silva E, Teixeira A, David L, Carneiro F, Reis CA, Sobrinho-Simoes J, Serpa J, Veerman E, Bolscher J, Sobrinho-Simoes M: Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virch Arch 440: 311–317, 2002Google Scholar
  33. 33.
    Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K: Distinction of differenciated type early gastric carcinoma with gastric type mucin expression. Cancer 89: 724–732, 2000Google Scholar
  34. 34.
    Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K: Gastric and Intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 le-sions. Oncology 61: 212–220, 2001Google Scholar
  35. 35.
    Lopez-Ferrer A, De Bolos C, Barranco C, Garrido M, Isern J, Carlsted I, Reis CA, Torrado J, Real FX: Role of fucosyletransferase in the association between apomucin and lewis antigen expression in normal and malignant gastric epithelium. Gut 47: 349–356, 2000Google Scholar
  36. 36.
    Carneiro F, Seixas M, Sobrinho-Simoes M: New elements for an updated classification of the carcinomas of the stomach. Path Res Pract 191: 571–584, 1995Google Scholar
  37. 37.
    Riberio MM, Seixas M, Sobrinho-Simoes M: Prognosis in gastric carcinoma. The preminence of staging and fu-tulity of histological classification. Dig Dis Pathol 1: 51–68, 1988Google Scholar
  38. 38.
    Fiocca R, Villani L, Tenti P, Solcia E, Cornaggia M, Frigerio B, Capella C: Characterization of four main cell types in gastric cancer: Foveolar, mucopeptic, intestinal columnar and goblet cells. Path Res Pract 182: 308–325, 1987Google Scholar
  39. 39.
    Bartman AE, Sanderson SJ, Ewing SL, Niehans GA, Wiehr CL, Evans MK, Ho SB: Aberant expression of MUC5AC and MUC 6 gastric mucin genes in colorectal polyps. Int J Cancer 8: 210–218, 1999Google Scholar
  40. 40.
    Buisine MP, Janin A, Maunoury V, Audie JP, Delescaut MP, Copin MC, Colombei JF, Degand P, Aubert JP, Porchet N: Aberant expres-sion of a human mucin gene (MUC 5AC) in rectosigmoid villous adenoma. Gastroenterology 110: 84–91, 1996Google Scholar
  41. 41.
    Kocer B, Soran A, Erdogan S, Karabeyoglu M, Yildirim O, Eroglu A, Bozkurt B, Cengiz O: Expression of MUC5AC in colorectal carcinoma and its relationship with prognosis. Path Int 52: 470–477, 2002Google Scholar
  42. 42.
    Bara J, Chastre E, Mahiou J, Singh RL: Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 75: 767–773, 1998Google Scholar
  43. 43.
    Pigny P, Guyonnet-Duperat V, Hill AS, Prett WS, Galieque-Zouitina S, d'Hooge MC, Laine A, Van-Seuningen I, Degand P, Gum JR, Kim YS, Swallow DM, Aubert JP, Porchet N: Human mucin genes assigned to 11p15. 5: Identification and organisation of a cluster of genes. Genomics 38: 340–352, 1996Google Scholar

Copyright information

© Plenum Publishing Corporation 2004

Authors and Affiliations

  • Belma Kocer
    • 1
  • Atilla Soran
    • 1
  • Gulten Kiyak
    • 1
  • Sibel Erdogan
    • 2
  • Abdullah Eroglu
    • 1
  • Betül Bozkart
    • 1
  • Cem Solak
    • 1
  • Omer Cengiz
    • 1
  1. 1.2nd General SurgeryUSA
  2. 2.Pathology DeparmentsAnkaray Numune Teaching and Research HospitalAnkaraTurkey

Personalised recommendations